New Insights into the Cell Biology of Hematopoietic Progenitors by Studying Prominin-1 (CD133)

Prominin-1 (alias CD133) has received considerable interest because of its expression by several stem and progenitor cells originating from various sources, including the neural and hematopoietic systems. As a cell surface marker, prominin-1 is now used for somatic stem cell isolation. Its expression in cancer stem cells has broadened its clinical value, as it might be useful to outline new prospects for more effective cancer therapies by targeting tumor-initiating cells. Cell biological studies of this molecule have demonstrated that it is specifically concentrated in various membrane structures that protrude from the planar areas of the plasmalemma. Prominin-1 binds to the plasma membrane cholesterol and is associated with a particular membrane microdomain in a cholesterol-dependent manner. Although its physiological function is not yet determined, it is becoming clear that this cell surface protein, as a unique marker of both plasma membrane protrusions and membrane microdomains, might reveal new aspects of the cell biology of rare stem and cancer stem cells. The aim of this review is to outline the recent discoveries regarding the dynamic reorganization of the plasma membrane of rare CD133+ hematopoietic progenitor cells during cell migration and division.

[1]  W. Huttner,et al.  Stem Cell Marker Prominin-1/AC133 Is Expressed in Duct Cells of the Adult Human Pancreas , 2008, Pancreas.

[2]  W. Huttner,et al.  Focus on molecules: prominin-1 (CD133). , 2007, Experimental eye research.

[3]  W. Huttner,et al.  Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice , 2007, Histochemistry and Cell Biology.

[4]  H. Malech,et al.  The Late Dividing Population of γ‐Retroviral Vector Transduced Human Mobilized Peripheral Blood Progenitor Cells Contributes Most to Gene‐Marked Cell Engraftment in Nonobese Diabetic/Severe Combined Immunodeficient Mice , 2007, Stem cells.

[5]  P. Sieving,et al.  Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene , 2007, Human Genetics.

[6]  P. Wernet,et al.  Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. , 2007, Blood.

[7]  W. Huttner,et al.  Nomenclature of prominin-1 (CD133) splice variants - an update. , 2007, Tissue antigens.

[8]  H. Gerdes,et al.  Tunneling nanotubes: A new route for the exchange of components between animal cells , 2007, FEBS letters.

[9]  D. Corbeil,et al.  GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells , 2007, FEBS letters.

[10]  A. Ho,et al.  The Many Facets of SDF-1α, CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells , 2007, Journal of biomedicine & biotechnology.

[11]  Linda Yang,et al.  Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow , 2007, Proceedings of the National Academy of Sciences.

[12]  W. Huttner,et al.  Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1 , 2007, The Journal of cell biology.

[13]  V. Beneš,et al.  Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. , 2007, Experimental hematology.

[14]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[15]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[16]  W. Huttner,et al.  Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine , 2007, Cell and Tissue Research.

[17]  S. Morrison,et al.  Maintaining hematopoietic stem cells in the vascular niche. , 2006, Immunity.

[18]  C. Werner,et al.  Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. , 2006, Stem cells and development.

[19]  Linheng Li,et al.  Understanding hematopoietic stem-cell microenvironments. , 2006, Trends in biochemical sciences.

[20]  David A. Williams,et al.  Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment. , 2006, Blood.

[21]  D. Freund,et al.  Comparative analysis of proliferative potential and clonogenicity of MACS‐immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor , 2006, Cell proliferation.

[22]  David A. Williams,et al.  The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization. , 2006, Experimental hematology.

[23]  O. Kollet,et al.  Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. , 2006, Experimental hematology.

[24]  L. Pike.  Rafts defined: a report on the Keystone symposium on lipid rafts and cell function Published, JLR Papers in Press, April 27, 2006. , 2006, Journal of Lipid Research.

[25]  N. Van Overstraeten-Schlögel,et al.  Role of stromal‐derived factor‐1 in the hematopoietic‐supporting activity of human mesenchymal stem cells , 2006, European journal of haematology.

[26]  W. Huttner,et al.  Prominin-1 (CD133): from progenitor cells to human diseases , 2006 .

[27]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[28]  A. Trumpp,et al.  Bone-marrow haematopoietic-stem-cell niches , 2006, Nature Reviews Immunology.

[29]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[30]  Wolfgang Wagner,et al.  Hematopoietic Progenitor Cells and Cellular Microenvironment: Behavioral and Molecular Changes upon Interaction , 2005, Stem cells.

[31]  W. Huttner,et al.  Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells , 2005, Journal of Cell Science.

[32]  E. Fibach,et al.  Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells. , 2005, Experimental hematology.

[33]  W. Huttner,et al.  Isolation of neural stem cells from the postnatal cerebellum , 2005, Nature Neuroscience.

[34]  K. Boheler,et al.  Somatic Stem Cell Marker Prominin‐1/CD133 Is Expressed in Embryonic Stem Cell–Derived Progenitors , 2005, Stem cells.

[35]  A. Kiani,et al.  Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells , 2005, Leukemia.

[36]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[37]  P. Wernet,et al.  Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. , 2004, Blood.

[38]  W. Huttner,et al.  Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis , 2004, Journal of Cell Science.

[39]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[40]  Giulio Cossu,et al.  Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. , 2004, The Journal of clinical investigation.

[41]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[42]  W. Huttner,et al.  Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells , 2004, The EMBO journal.

[43]  D. Qujeq,et al.  Cell cycle analysis of the CD133+ and CD133- cells isolated from umbilical cord blood. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[44]  K. Ohashi,et al.  CD29 integrin‐ and LIMK1/cofilin‐mediated actin reorganization regulates the migration of haematopoietic progenitor cells underneath bone marrow stromal cells , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[45]  L. Pike.  Lipid rafts: heterogeneity on the high seas. , 2004, The Biochemical journal.

[46]  H. Einsele,et al.  Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors , 2004, British journal of haematology.

[47]  K. Ohashi,et al.  CD29 integrin‐ and LIMK1/cofilin‐mediated actin reorganization regulates the migration of haematopoietic progenitor cells underneath bone marrow stromal cells , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[48]  T. Kuwana,et al.  Nanotubular Highways for Intercellular Organelle Transport , 2004 .

[49]  W. Huttner,et al.  Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer , 2004, Cell and Tissue Research.

[50]  A. Straube,et al.  Expression of Neuronal Markers in Differentiated Marrow Stromal Cells and CD133+ Stem-Like Cells , 2003, Cell transplantation.

[51]  W. Huttner,et al.  AC133 Antigen, CD133, Prominin‐1, Prominin‐2, Etc.: Prominin Family Gene Products in Need of a Rational Nomenclature , 2003, Stem cells.

[52]  G. Seitz,et al.  Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. , 2003, Blood.

[53]  R. Handgretinger,et al.  Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells , 2003, Bone Marrow Transplantation.

[54]  P. Fu,et al.  Expansion of LTC‐ICs and Maintenance of p21 and BCL‐2 Expression in Cord Blood CD34+/CD38− Early Progenitors Cultured over Human MSCs as a Feeder Layer , 2002, Stem cells.

[55]  O. Kollet,et al.  The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice , 2002, Leukemia.

[56]  J. Bischoff,et al.  AC133-2, a Novel Isoform of Human AC133 Stem Cell Antigen* 210 , 2002, The Journal of Biological Chemistry.

[57]  E. Seifried,et al.  Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia , 2002, Bone Marrow Transplantation.

[58]  A. Ho,et al.  Functional characterization of podia formation in normal and malignant hematopoietic cells , 2002, Journal of leukocyte biology.

[59]  Irving L. Weissman,et al.  Physiological Migration of Hematopoietic Stem and Progenitor Cells , 2001, Science.

[60]  M. Bhatia.  AC133 expression in human stem cells , 2001, Leukemia.

[61]  D. Soligo,et al.  Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.

[62]  C. Martínez-A,et al.  Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Quesenberry,et al.  The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia , 2001, British journal of haematology.

[64]  Katja Röper,et al.  Prominin: A Story of Cholesterol, Plasma Membrane Protrusions and Human Pathology , 2001, Traffic.

[65]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Gerson,et al.  Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. , 2000, Journal of hematotherapy & stem cell research.

[67]  I. Bernstein,et al.  Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. , 2000, Journal of cell science.

[68]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[69]  W. Huttner,et al.  Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane , 2000, Nature Cell Biology.

[70]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .

[71]  M. Bhatia,et al.  Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. , 2000, Blood.

[72]  T. Nakano,et al.  In Vitro Proliferation Potential of AC133 Positive Cells in Peripheral Blood , 2000, Stem cells.

[73]  Dzung H. Nguyen,et al.  Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.

[74]  W. Huttner,et al.  The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane Protrusions* , 2000, The Journal of Biological Chemistry.

[75]  W. Huttner,et al.  A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. , 2000, Human molecular genetics.

[76]  W. Huttner,et al.  Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - a combination of apical sorting and retention in plasma membrane protrusions. , 1999, Journal of cell science.

[77]  M. A. Pozo,et al.  EMBO MEMBER'S REVIEW Leukocyte polarization in cell migration and immune interactions , 1999 .

[78]  W. Berdel,et al.  Expression of AC133, a Novel Stem Cell Marker, on Human Leukemic Blasts Lacking CD34− Antigen and on a Human CD34+ Leukemic Cell Line: MUTZ-2 , 1998 .

[79]  B. Lord,et al.  CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.

[80]  H. Serve,et al.  Expression of a AC133, a novel stem cell marker, on human leukemic blasts lacking CD34-antigen and on a human CD34+ leukemic line:MUTZ-2. , 1998, Blood.

[81]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[82]  R. Warnke,et al.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.

[83]  W. Huttner,et al.  Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[85]  F Beaujean,et al.  Methods of CD34+ cell separation: comparative analysis. , 1997, Transfusion Science.

[86]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[87]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[88]  C. Craddock,et al.  The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  C. Hardy.  The Homing of Hematopoietic Stem Cells to the Bone Marrow , 1995, The American journal of the medical sciences.

[90]  C. Craddock,et al.  VLA4/VCAM‐1接着経路が骨髄とひ臓の間で移植したマウス造血幹細胞の対照的な定着機構を決定する , 1995 .

[91]  N. Sato,et al.  Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons , 1993, The Journal of cell biology.

[92]  Daniel S. Weld.  Comparative Analysis , 1987, IJCAI.

[93]  L. Lajtha,et al.  Conditions controlling the proliferation of haemopoietic stem cells in vitro , 1977, Journal of cellular physiology.

[94]  M. Bhatia,et al.  Isolation and characterization of human CD 34 2 Lin 2 and CD 34 1 Lin 2 hematopoietic stem cells using cell surface markers AC 133 and CD 7 , 2022 .